What is the primary purpose of the IDEXX Laboratories, Inc. 2014 Incentive Compensation Plan?

The primary purpose of the 2014 Plan is to allow the company to make annual incentive compensation payments to its Chief Executive Officer and certain other executive officers in a manner that is not subject to the deduction limitations under Section 162(m) of the Internal Revenue Code. This helps ensure that performance-based compensation remains tax-deductible for the company.

What were the results of the director elections at the annual meeting?

The company's stockholders elected all three nominated candidates for Class II director positions to serve three-year terms. The voting results indicate strong support for the nominated directors.

Was the company's executive compensation approved by stockholders?

Yes, the stockholders approved the non-binding advisory resolution on the company's executive compensation. This vote, while advisory, signals stockholder support for the company's compensation practices.

Who will serve as IDEXX's independent auditor for fiscal year 2014?

The appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the 2014 fiscal year was ratified by the stockholders.

IDXX 8-K: Leadership Changes & Shareholder Matters

Summary

This 8-K filing from IDEXX LABORATORIES INC /DE (IDXX) on May 9, 2014, primarily details the outcomes of their 2014 Annual Meeting of Stockholders held on May 7, 2014. The key information for investors revolves around the approval of the IDEXX Laboratories, Inc. 2014 Incentive Compensation Plan (the "2014 Plan"). This plan is designed to allow for annual incentive compensation payments to executive officers that qualify for exemptions from deduction limitations under Section 162(m) of the Internal Revenue Code, aiming to align executive compensation with performance while maintaining tax efficiency. Additionally, the filing confirms the election of three Class II directors for three-year terms, the approval of a non-binding advisory resolution on executive compensation, and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year 2014. The overwhelming support for these proposals indicates continued stockholder confidence in the company's leadership and governance structure.

Key Highlights

1Stockholders approved the IDEXX Laboratories, Inc. 2014 Incentive Compensation Plan, crucial for executive compensation strategy and tax efficiency.
2Three Class II directors were elected to three-year terms, reflecting continuity in board leadership.
3A non-binding advisory vote on executive compensation received strong stockholder approval.
4The appointment of PricewaterhouseCoopers LLP as the independent auditor for fiscal year 2014 was ratified.
5The 2014 Plan is designed to ensure that incentive compensation paid to the CEO and other key executives remains deductible under Section 162(m) of the IRS code.
6The filing incorporates by reference details of the 2014 Plan from the company's definitive proxy statement filed on March 25, 2014.

IDEXX LABORATORIES INC /DE 8-K Report, Executive Changes (May 9, 2014)

Summary

Key Highlights

Frequently Asked Questions